(S,R,S)-AHPC-PEG1-NH2 dihydrochloride

 CAS No.: 2341796-83-4  Cat No.: BP-100112  Purity: ≥95% by HPLC 4.5  

(S,R,S)-AHPC-PEG1-NH2 dihydrochloride is a premium E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) drug discovery and research. This compound features the potent VHL E3 ligase ligand AHPC, conjugated via a single PEG1 linker to an amine group, which allows versatile conjugation to various target protein ligands. As a crucial building block in PROTAC synthesis, (S,R,S)-AHPC-PEG1-NH2 dihydrochloride serves to efficiently recruit VHL E3 ubiquitin ligase to promote specific ubiquitination and degradation of protein targets. The product plays a pivotal role in targeted protein degradation technology, a leading platform for the development of next-generation therapeutics, especially for disease targets previously considered 'undruggable.' Ideal for medicinal chemistry, chemical biology, and preclinical study, this E3 ligase ligand-linker enables customized PROTAC molecule construction for research into oncology, neurodegeneration, and other therapeutic areas.

(S,R,S)-AHPC-PEG1-NH2 dihydrochloride

Structure of 2341796-83-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
E3 Ligase Ligand-Linker Conjugate
Molecular Formula
C₂₆H₃₉Cl₂N₅O₅S
Molecular Weight
604.59

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
≥95% by HPLC
Storage
Store at -20°C
Shipping
Room temperature in continental US; may vary elsewhere.
IUPACName
(2S,4R)-1-[(2S)-2-[[2-(2-aminoethoxy)acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;dihydrochloride
Synonyms
VH032-PEG1-NH2 dihydrochloride
InChI
1S/C26H37N5O5S.2ClH/c1-16-22(37-15-29-16)18-7-5-17(6-8-18)12-28-24(34)20-11-19(32)13-31(20)25(35)23(26(2,3)4)30-21(33)14-36-10-9-27;;/h5-8,15,19-20,23,32H,9-14,27H2,1-4H3,(H,28,34)(H,30,33);2*1H/t19-,20+,23-;;/m1../s1
Canonical SMILES
CC1=C(C2=CC=C(C=C2)CNC([C@@H]3C[C@H](CN3C([C@H](C(C)(C)C)NC(COCCN)=O)=O)O)=O)SC=N1.Cl.Cl

Background Introduction

(S,R,S)-AHPC-PEG1-NH2 dihydrochloride is a specially designed E3 ligase ligand-linker conjugate tailored for targeted protein degradation research. As a building block for PROTAC (Proteolysis Targeting Chimera) synthesis, this molecule features the von Hippel-Lindau (VHL) ligand (AHPC) coupled to an amino-terminated polyethylene glycol (PEG1) linker, presented in its dihydrochloride salt form to enhance solubility and stability. This unique structure allows researchers to efficiently couple the ligand to various protein-targeting moieties, facilitating custom PROTAC development for chemical biology and drug discovery applications.

Mechanism

The mechanism of (S,R,S)-AHPC-PEG1-NH2 dihydrochloride centers on its role as a modular E3 ligase recruiting unit in PROTAC design. The AHPC fragment specifically binds to the VHL E3 ubiquitin ligase complex, while the PEG1 linker enables flexible attachment to a ligand for the protein of interest. When assembled into a complete PROTAC molecule, the VHL-recruiting AHPC moiety brings the E3 ligase into close proximity with the target protein. This proximity promotes ubiquitination and subsequent proteasomal degradation of the target. The NH2 terminus of the linker provides convenient chemical functionality for conjugation to a variety of warheads or protein binding modules.

Applications

(S,R,S)-AHPC-PEG1-NH2 dihydrochloride is widely applied in the design and synthesis of PROTACs for both basic research and drug discovery. Its primary use is as an E3 ligase recruiting element, allowing researchers to target disease-relevant proteins for degradation via the ubiquitin-proteasome system. This conjugate is ideal for rapid structure-activity relationship (SAR) studies, exploration of novel protein degradation targets, and development of next-generation therapeutics for cancer, neurodegenerative diseases, and autoimmune conditions. The ready-to-use PEG1 linker enhances solubility and cellular permeability, making it a versatile platform for chemical biology, medicinal chemistry, and targeted protein degradation studies.

• Versatile PEG1 linker increases solubility and flexibility in PROTAC design, enabling more efficient protein degradation.
• Amine-terminated structure allows straightforward conjugation to diverse warheads, streamlining von Hippel-Lindau (VHL)-based PROTAC synthesis.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
Germany
Inquiry Basket